X
Type 2 diabetes research: fewer side effects from modified medication
https://pharmaphorum.com/news/diabetes-research-modified-medication/
Diabetes
Novo Nordisk undeterred after losing out on Ablynx takeover
After losing out to Sanofi in its pursuit of Belgian biotech Ablynx earlier this week, Novo Nordisk has put a brave face on the disappointment.
Lilly looks to devices to revive diabetes division
Dexcom continuous glucose monitors to become part of Lilly’s Connected Devices Ecosystem.
As competition hots up, J&J exits insulin pump market
A total of 297 employees to be laid off.
Automatic artificial pancreas shows promise in trial
Experimental device requires no user input at all.
Fitbit and Dexcom to bring diabetes data to Ionic smartwatch
Dexcom G5 Mobile data will be displayed on Fitbit’s Ionic smartwatch.
1 2
